JP7463273B2 - 流動性無細胞組織マトリックス製品および製造方法 - Google Patents

流動性無細胞組織マトリックス製品および製造方法 Download PDF

Info

Publication number
JP7463273B2
JP7463273B2 JP2020514969A JP2020514969A JP7463273B2 JP 7463273 B2 JP7463273 B2 JP 7463273B2 JP 2020514969 A JP2020514969 A JP 2020514969A JP 2020514969 A JP2020514969 A JP 2020514969A JP 7463273 B2 JP7463273 B2 JP 7463273B2
Authority
JP
Japan
Prior art keywords
tissue
tissue matrix
composition
matrix particles
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020514969A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500092A (ja
JP2021500092A5 (enExample
Inventor
シュ，フゥイ
リ，フゥイ
ポマリュ，ミン，エフ．
メッシナ，ダリン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeCell Corp
Original Assignee
LifeCell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeCell Corp filed Critical LifeCell Corp
Publication of JP2021500092A publication Critical patent/JP2021500092A/ja
Publication of JP2021500092A5 publication Critical patent/JP2021500092A5/ja
Priority to JP2024050815A priority Critical patent/JP2024096720A/ja
Application granted granted Critical
Publication of JP7463273B2 publication Critical patent/JP7463273B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
JP2020514969A 2017-10-19 2018-10-19 流動性無細胞組織マトリックス製品および製造方法 Active JP7463273B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024050815A JP2024096720A (ja) 2017-10-19 2024-03-27 流動性無細胞組織マトリックス製品および製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762574678P 2017-10-19 2017-10-19
US62/574,678 2017-10-19
PCT/US2018/056630 WO2019079672A1 (en) 2017-10-19 2018-10-19 ACELLULAR TISSUE MATRIX PRODUCTS FLUIDS AND METHODS OF PRODUCTION

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024050815A Division JP2024096720A (ja) 2017-10-19 2024-03-27 流動性無細胞組織マトリックス製品および製造方法

Publications (3)

Publication Number Publication Date
JP2021500092A JP2021500092A (ja) 2021-01-07
JP2021500092A5 JP2021500092A5 (enExample) 2021-11-25
JP7463273B2 true JP7463273B2 (ja) 2024-04-08

Family

ID=64267930

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020514969A Active JP7463273B2 (ja) 2017-10-19 2018-10-19 流動性無細胞組織マトリックス製品および製造方法
JP2024050815A Withdrawn JP2024096720A (ja) 2017-10-19 2024-03-27 流動性無細胞組織マトリックス製品および製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024050815A Withdrawn JP2024096720A (ja) 2017-10-19 2024-03-27 流動性無細胞組織マトリックス製品および製造方法

Country Status (8)

Country Link
US (3) US11826488B2 (enExample)
EP (2) EP4309686A3 (enExample)
JP (2) JP7463273B2 (enExample)
CN (1) CN111225690A (enExample)
AU (2) AU2018351314A1 (enExample)
CA (1) CA3075106A1 (enExample)
ES (1) ES2960617T3 (enExample)
WO (1) WO2019079672A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3697460A1 (en) 2017-10-18 2020-08-26 LifeCell Corporation Adipose tissue products and methods of production
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
CA3142151A1 (en) 2019-05-30 2020-12-03 Lifecell Corporation Biologic breast implant
WO2021119468A1 (en) * 2019-12-12 2021-06-17 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
CN116212112A (zh) * 2023-03-21 2023-06-06 北京桀亚莱福生物技术有限责任公司 一种注射填充材料及其制备和应用
KR20250144958A (ko) * 2024-03-27 2025-10-13 주식회사 도프 무세포 진피 기질 마이크로 입자를 포함하는 분산액, 이를 포함하는 필러 및 이의 용도

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013533093A (ja) 2010-08-10 2013-08-22 ライフセル コーポレーション 再生組織足場
JP2013544583A (ja) 2010-11-08 2013-12-19 アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエ ヒアルロン酸ベースの製剤
JP2016527338A (ja) 2013-06-11 2016-09-08 アンティース ソシエテ アノニム ヒアルロン酸の架橋方法；注射用ハイドロゲルの調製方法；得られるハイドロゲル；得られるハイドロゲルの使用
WO2017139100A1 (en) 2016-02-08 2017-08-17 Lifecell Corporation Biologic breast implant

Family Cites Families (165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1562244A (en) 1976-11-11 1980-03-05 Lock P M Wound dressing materials
US4569348A (en) 1980-02-22 1986-02-11 Velcro Usa Inc. Catheter tube holder strap
US4373519A (en) 1981-06-26 1983-02-15 Minnesota Mining And Manufacturing Company Composite wound dressing
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
CA1295796C (en) 1984-03-27 1992-02-18 Conrad Whyne Biodegradable matrix and methods for producing same
US4969912A (en) 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
CA2002261A1 (en) 1988-11-07 1990-05-07 Andreas Sommer High molecular weight human angiogenic factors
JP2719671B2 (ja) 1989-07-11 1998-02-25 日本ゼオン株式会社 創傷被覆材
US5290558A (en) 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5131850A (en) 1989-11-03 1992-07-21 Cryolife, Inc. Method for cryopreserving musculoskeletal tissues
US5104957A (en) 1990-02-28 1992-04-14 Autogenesis Technologies, Inc. Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
US8067149B2 (en) 1990-09-12 2011-11-29 Lifecell Corporation Acellular dermal matrix and method of use thereof for grafting
CA2051092C (en) 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
US5231169A (en) 1990-10-17 1993-07-27 Norian Corporation Mineralized collagen
US5263971A (en) 1991-02-13 1993-11-23 Life Medical Sciences, Inc. Apparatus for the closure of wide skin defects by stretching of skin
US5254133A (en) 1991-04-24 1993-10-19 Seid Arnold S Surgical implantation device and related method of use
US5149331A (en) 1991-05-03 1992-09-22 Ariel Ferdman Method and device for wound closure
US5160313A (en) 1991-05-14 1992-11-03 Cryolife, Inc. Process for preparing tissue for transplantation
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US5645081A (en) 1991-11-14 1997-07-08 Wake Forest University Method of treating tissue damage and apparatus for same
US7198046B1 (en) 1991-11-14 2007-04-03 Wake Forest University Health Sciences Wound treatment employing reduced pressure
US5275826A (en) 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5641518A (en) 1992-11-13 1997-06-24 Purdue Research Foundation Method of repairing bone tissue
US5437651A (en) 1993-09-01 1995-08-01 Research Medical, Inc. Medical suction apparatus
US5549584A (en) 1994-02-14 1996-08-27 The Kendall Company Apparatus for removing fluid from a wound
DE69532976T2 (de) 1994-03-14 2005-05-04 Cryolife, Inc. Herstellungsverfahren von gewebe zur implantation
US5489304A (en) 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
US5906827A (en) 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
US5599852A (en) 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
US5622867A (en) 1994-10-19 1997-04-22 Lifecell Corporation Prolonged preservation of blood platelets
US6485723B1 (en) 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
US5834232A (en) 1996-05-01 1998-11-10 Zymogenetics, Inc. Cross-linked gelatin gels and methods of making them
US6666892B2 (en) 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
CA2267449C (en) 1996-11-05 2008-10-14 Purdue Research Foundation Myocardial graft constructs
US6998418B1 (en) 1996-11-05 2006-02-14 Gp Medical, Inc. Acellular biological material chemically treated with genipin
AUPO599897A0 (en) 1997-04-03 1997-05-01 Vidal, Linus Clear collagen for facial implants
US5993844A (en) 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
US6135116A (en) 1997-07-28 2000-10-24 Kci Licensing, Inc. Therapeutic method for treating ulcers
US6613278B1 (en) 1998-11-13 2003-09-02 Regeneration Technologies, Inc. Tissue pooling process
GB9719520D0 (en) 1997-09-12 1997-11-19 Kci Medical Ltd Surgical drape and suction heads for wound treatment
US6371992B1 (en) 1997-12-19 2002-04-16 The Regents Of The University Of California Acellular matrix grafts: preparation and use
US6071267A (en) 1998-02-06 2000-06-06 Kinetic Concepts, Inc. Medical patient fluid management interface system and method
US6326018B1 (en) 1998-02-27 2001-12-04 Musculoskeletal Transplant Foundation Flexible sheet of demineralized bone
US20030039678A1 (en) 1998-03-16 2003-02-27 Stone Kevin R. Xenograft bone matrix for orthopedic applications
US6179872B1 (en) 1998-03-17 2001-01-30 Tissue Engineering Biopolymer matt for use in tissue repair and reconstruction
US5951597A (en) 1998-04-14 1999-09-14 Cardiac Pacemakers, Inc. Coronary sinus lead having expandable matrix anchor
US6432710B1 (en) 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
EP1082006B1 (en) 1998-05-26 2006-02-01 Lifecell Corporation Cryopreservation of human red blood cells
US6933326B1 (en) * 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
DE69941216D1 (de) 1998-06-19 2009-09-17 Lifecell Corp Teilchenförmige zellfreie gewebematrix
WO2000016822A1 (en) 1998-09-21 2000-03-30 The Brigham And Women's Hospital, Inc. Compositions and methods for tissue repair
US6565874B1 (en) 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
WO2000047114A1 (en) 1999-02-12 2000-08-17 Collagenesis, Inc. Injectable collagen-based delivery system for bone morphogenic proteins
US6856821B2 (en) 2000-05-26 2005-02-15 Kci Licensing, Inc. System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure
US6599318B1 (en) 1999-11-30 2003-07-29 Shlomo Gabbay Implantable support apparatus and method of using same
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
AU9109201A (en) 2000-09-18 2002-03-26 Organogenesis Inc Methods for treating a patient using a bioengineered flat sheet graft prostheses
IL139708A0 (en) 2000-11-15 2002-02-10 Amiel Gilad Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US7070584B2 (en) 2001-02-20 2006-07-04 Kci Licensing, Inc. Biocompatible wound dressing
AU2002329884A1 (en) * 2001-08-27 2003-03-10 Regeneration Technologies, Inc. Processed soft tissue for topical or internal application
WO2003032735A1 (en) 2001-10-18 2003-04-24 Lifecell Corporation Remodeling of tissues and organs
JP4624678B2 (ja) 2002-02-21 2011-02-02 パイオニア・サージカル・オーソバイオロジックス，インコーポレイテッド 架橋生物活性ヒドロゲルマトリックス
AU2003225516A1 (en) 2002-03-26 2003-10-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Responsive biomedical composites
US20030225347A1 (en) 2002-06-03 2003-12-04 Argenta Louis C. Directed tissue growth employing reduced pressure
US7498040B2 (en) 2005-10-12 2009-03-03 Lifenet Health Compositions for repair of defects in osseous tissues, and methods of making the same
US20040037735A1 (en) 2002-08-23 2004-02-26 Depaula Carl Alexander Allograft tissue purification process for cleaning bone
US7402319B2 (en) 2002-09-27 2008-07-22 Board Of Regents, The University Of Texas System Cell-free tissue replacement for tissue engineering
US6840960B2 (en) 2002-09-27 2005-01-11 Stephen K. Bubb Porous implant system and treatment method
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US7208171B2 (en) 2002-10-31 2007-04-24 Northwestern University Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation
US7115100B2 (en) 2002-11-15 2006-10-03 Ethicon, Inc. Tissue biopsy and processing device
US20040162613A1 (en) 2003-02-06 2004-08-19 Thomas Roballey Cosmetic and reconstructive prosthesis containing a biologically compatible rupture indicator
FR2856305B1 (fr) 2003-06-19 2007-08-24 Inst Nat Sante Rech Med Protheses avec revetements biologiquement actifs
CA2530421C (en) 2003-06-27 2015-04-21 Ethicon, Incorporated Repair and regeneration of ocular tissue using postpartum-derived cells
WO2005009134A1 (en) 2003-07-21 2005-02-03 Lifecell Corporation ACELLULAR TISSUE MATRICES MADE FROM GALACTOSE α-1,3-GALACTOSE-DEFICIENT TISSUE
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
CA2857051A1 (en) 2004-03-17 2005-09-29 David Ayares Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase
KR100680134B1 (ko) 2004-06-10 2007-02-08 박우삼 무세포 진피를 주사가능하도록 입자 형태로 가공한 필러
US20060058892A1 (en) 2004-09-16 2006-03-16 Lesh Michael D Valved tissue augmentation implant
US20060073592A1 (en) 2004-10-06 2006-04-06 Wendell Sun Methods of storing tissue matrices
US7905826B2 (en) 2004-11-03 2011-03-15 Cook Incorporated Methods for modifying vascular vessel walls
DE102005002644A1 (de) 2005-01-19 2006-07-20 Schülke & Mayr GmbH Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung
CA2604856A1 (en) 2005-04-25 2006-11-02 Eric F. Bernstein Dermal fillers for biomedical applications in mammals and methods of using the same
US20070014869A1 (en) * 2005-07-15 2007-01-18 Cormatrix Cardiovascular, Inc. Compositions for reconstruction, replacement or repair of intracardiac tissue
ES2668551T3 (es) 2005-09-26 2018-05-18 Lifecell Corporation Composición seca de plaquetas
US7498041B2 (en) 2005-10-12 2009-03-03 Lifenet Health Composition for repair of defects in osseous tissues
JP5002805B2 (ja) 2005-10-14 2012-08-15 財団法人ヒューマンサイエンス振興財団 生物由来スキャフォールドの作製方法
CN102600548A (zh) 2006-02-09 2012-07-25 阿德兰斯研究学院有限公司 测微计辅助流体输送装置
US8029498B2 (en) 2006-03-14 2011-10-04 Kci Licensing Inc. System for percutaneously administering reduced pressure treatment using balloon dissection
US9456860B2 (en) 2006-03-14 2016-10-04 Kci Licensing, Inc. Bioresorbable foaming tissue dressing
US20070248575A1 (en) 2006-04-19 2007-10-25 Jerome Connor Bone graft composition
US8753672B2 (en) 2006-04-24 2014-06-17 Coloplast A/S Gelatin non-woven structures produced by a non-toxic dry solvent spinning process
EP3505137A1 (en) 2006-05-09 2019-07-03 LifeCell Corporation Reinforced biological tissue
JP5050197B2 (ja) 2006-07-31 2012-10-17 財団法人ヒューマンサイエンス振興財団 生物由来スキャフォールドの作製方法
WO2008060475A2 (en) 2006-11-09 2008-05-22 Kci Licensing Inc. Porous bioresorbable linked dressing comprising microspheres and methods of making same
MX2009010387A (es) 2007-03-26 2009-10-19 Baxter Int Relleno de vacio inyectable para el aumento de tejido blando.
JP2010524644A (ja) 2007-04-26 2010-07-22 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 内腔器官用の組織工学装置及び方法
US9034367B2 (en) 2007-05-10 2015-05-19 Cormatrix Cardiovascular, Inc. Articles for tissue regeneration with biodegradable polymer
WO2009006226A1 (en) 2007-06-29 2009-01-08 Kci Licensing Inc. Activation of bone and cartilage formation
EP3473260B1 (en) 2007-07-10 2020-09-23 LifeCell Corporation Acellular tissue matrix compositions for tissue repair
US9744043B2 (en) 2007-07-16 2017-08-29 Lifenet Health Crafting of cartilage
US9161970B2 (en) 2007-12-12 2015-10-20 Allergan, Inc. Dermal filler
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
EP2698173A1 (en) 2008-02-29 2014-02-19 Coloplast A/S Compositions and methods for augmentation and regeneration of living tissue in a subject
CA2723952C (en) 2008-05-13 2014-07-08 Jonathan Kagan Catheter/filament style device and methods for treatment of wounds beneath the surface of the skin
AU2009256193B2 (en) 2008-06-06 2015-04-23 Lifecell Corporation Elastase treatment of tissue matrices
AU2009262183B2 (en) 2008-06-25 2013-07-18 Kci Licensing, Inc. Absorbable, reduced-pressure manifolds and systems
KR20110022706A (ko) 2008-06-26 2011-03-07 케이씨아이 라이센싱 인코포레이티드 감압 치료 및 연골세포를 사용한 연골 형성의 자극
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
WO2010019753A2 (en) 2008-08-14 2010-02-18 Kci Licensing, Inc. Tissue scaffolds
US7927414B2 (en) 2008-09-05 2011-04-19 Ethicon, Inc. Method of manufacturing acellular matrix glue
ES2628100T3 (es) * 2008-09-30 2017-08-01 The Regents Of The University Of California Composiciones que comprenden matriz extracelular descelularizada obtenida a partir de tejido cardíaco
WO2010059783A2 (en) 2008-11-21 2010-05-27 Lifecell Corporation Reinforced biologic material
MX2011007080A (es) 2008-12-31 2011-10-17 Kci Licensing Inc Sistema para inducir el flujo de fluido para estimular el crecimiento de tejido.
US8734474B2 (en) 2008-12-31 2014-05-27 Kci Licensing, Inc. System for providing fluid flow to nerve tissues
CA2745867A1 (en) 2008-12-31 2010-07-08 Kci Licensing, Inc. Systems for providing fluid flow to tissues
CA2762212C (en) 2009-05-20 2015-12-29 Humacyte, Inc. Elastin for soft tissue augmentation
WO2011019822A2 (en) 2009-08-11 2011-02-17 The Johns Hopkins University Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
US20110171310A1 (en) 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
AU2011207543A1 (en) 2010-01-22 2012-07-26 Kci Licensing, Inc. Devices, systems, and methods for instillation of foamed fluid with negative pressure wound therapy
US8632512B2 (en) 2010-04-09 2014-01-21 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
EP3581211A1 (en) 2010-07-08 2019-12-18 LifeCell Corporation Method for shaping tissue matrices
CN102068714A (zh) 2011-01-19 2011-05-25 北京大学 一种胶原海绵及其制备方法
BR112013026200A2 (pt) 2011-04-14 2019-08-27 Lifecell Corp método para preparar uma composição de matriz de tecido, e matriz de tecido
KR20140033057A (ko) 2011-04-21 2014-03-17 사이토그래프트 티슈 엔지니어링, 인코포레이티드 세포-합성된 입자
WO2012166784A1 (en) 2011-05-31 2012-12-06 Lifecell Corporation Adipose tissue matrices
EP3243533B1 (en) * 2011-10-11 2020-06-17 Allergan Holdings France S.A.S. Threads of cross-linked hyaluronic acid and methods of use thereof
US20130121970A1 (en) 2011-11-10 2013-05-16 Lifecell Corporation Method for elimination of space through tissue approximation
EP3549615B1 (en) 2011-12-20 2020-12-16 LifeCell Corporation Sheet tissue products
EP3501558B1 (en) 2011-12-20 2020-11-25 LifeCell Corporation Flowable tissue products
US20130210058A1 (en) 2012-02-15 2013-08-15 Lakeland Ventures Development, Llc System for noninvasive determination of water in tissue
EP2841116A1 (en) 2012-04-24 2015-03-04 Lifecell Corporation Flowable tissue matrices
BR112014026088B1 (pt) * 2012-04-24 2019-11-05 Lifecell Corp produto de tratamento de tecidos
EP2968417A4 (en) 2013-03-15 2016-09-14 Univ Leland Stanford Junior INJECTABLE COMPOSITION FOR IN-SITU REPAIR AND RE-GENERATION OF INJURED TAPES OR TONES AND METHODS OF USE
WO2014198406A1 (en) 2013-06-11 2014-12-18 Anteis S.A. Method for crosslinking hyaluronic acid; method for preparing an injectable hydrogel; hydrogel obtained; use of the obtained hydrogel
WO2015048317A1 (en) * 2013-09-25 2015-04-02 The Children's Mercy Hospital Decellularized hyaline cartilage powder for tissue scaffolds
AU2015264025A1 (en) * 2014-05-21 2016-12-01 Mimedx Group, Inc. Micronized Wharton's jelly
CN105288702B (zh) * 2014-08-01 2018-11-02 山东大学 一种无细胞多糖真皮基质材料及其制备方法和应用
JP6499278B2 (ja) 2014-09-25 2019-04-10 アセル，インコーポレイテッド 細胞外マトリックス由来の多孔質フォーム、多孔質フォームｅｃｍ医療装置、並びに、それらの使用及び製造方法
KR101729127B1 (ko) 2014-10-24 2017-04-26 주식회사 엘앤씨바이오 입자형 무세포 진피와 히알루론산이 전자빔을 통해 물리적으로 가교된 생체 이식용 조성물의 제조방법
US10532126B2 (en) 2014-12-11 2020-01-14 Eth Zurich Graft scaffold for cartilage repair and process for making same
US9238090B1 (en) * 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
CN108289734B (zh) * 2015-08-17 2024-06-18 约翰·霍普金斯大学 用于组织恢复的间充质细胞结合复合材料
CN105107018B (zh) 2015-08-19 2018-08-24 李媚 一种无菌可注射材料的制备方法
GB201514788D0 (en) 2015-08-20 2015-10-07 Ecole Polytech Malleable scaffold material and uses thereof
CN106492288A (zh) * 2016-10-31 2017-03-15 广州昕生医学材料有限公司 可注射的脱细胞脂肪基质微粒及其在植入剂中的应用
AU2017382264A1 (en) 2016-12-23 2019-07-04 Lifecell Corporation Injectable polyurethanes and applications thereof
US12133930B2 (en) 2017-05-24 2024-11-05 Theramicro, Llc System and methods for soft-tissue augmentation
US11331412B2 (en) 2017-10-04 2022-05-17 Bio-Change Ltd. Cross-linked protein foams and methods of using thereof a polyvalent cellular scaffold
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
EP3697460A1 (en) 2017-10-18 2020-08-26 LifeCell Corporation Adipose tissue products and methods of production
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
US20200390944A1 (en) 2018-03-01 2020-12-17 Tepha, Inc. Medical devices containing compositions of poly(butylene succinate) and copolymers thereof
IL281898B2 (en) 2018-10-03 2024-09-01 Estab Labs S A Scaffolding for implantable medical devices and methods of use thereof
CA3142151A1 (en) 2019-05-30 2020-12-03 Lifecell Corporation Biologic breast implant
WO2020247793A1 (en) 2019-06-07 2020-12-10 Lifecell Corporation Injectable mesh

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013533093A (ja) 2010-08-10 2013-08-22 ライフセル コーポレーション 再生組織足場
JP2013544583A (ja) 2010-11-08 2013-12-19 アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエ ヒアルロン酸ベースの製剤
JP2016527338A (ja) 2013-06-11 2016-09-08 アンティース ソシエテ アノニム ヒアルロン酸の架橋方法；注射用ハイドロゲルの調製方法；得られるハイドロゲル；得られるハイドロゲルの使用
WO2017139100A1 (en) 2016-02-08 2017-08-17 Lifecell Corporation Biologic breast implant

Also Published As

Publication number Publication date
JP2024096720A (ja) 2024-07-17
WO2019079672A1 (en) 2019-04-25
JP2021500092A (ja) 2021-01-07
EP3697462B1 (en) 2023-07-12
US20250177606A1 (en) 2025-06-05
AU2024205015A1 (en) 2024-08-08
AU2018351314A1 (en) 2020-03-19
US20240226375A1 (en) 2024-07-11
ES2960617T3 (es) 2024-03-05
CN111225690A (zh) 2020-06-02
EP4309686A3 (en) 2024-02-07
EP3697462A1 (en) 2020-08-26
US20190117833A1 (en) 2019-04-25
US11826488B2 (en) 2023-11-28
CA3075106A1 (en) 2019-04-25
EP4309686A2 (en) 2024-01-24

Similar Documents

Publication Publication Date Title
JP7463273B2 (ja) 流動性無細胞組織マトリックス製品および製造方法
JP7559144B2 (ja) 脂肪組織製品および製造方法
US11246994B2 (en) Methods for introduction of flowable acellular tissue matrix products into a hand
Xia et al. Decellularized cartilage as a prospective scaffold for cartilage repair
EP1698358A1 (en) Transplantable biomaterial and method of preparing the same
US11123375B2 (en) Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
CN105169483A (zh) 一种脱细胞基质凝胶的制备方法及其脱细胞基质凝胶
He et al. Preparation and evaluation of acellular sheep periostea for guided bone regeneration
AU2016209422B2 (en) Tissue matrices with controlled porosity or mechanical properties
Zhang et al. Biomedical application of decellularized scaffolds
Liu et al. Robust, self-lubricating and injectable dECM-loaded hydrogels based on rapid photo-crosslinking for articular cartilage regeneration
JP2008228744A (ja) 生体由来移植用組織の石灰化を抑制するための処理方法および処理された組織
WO2021119468A1 (en) Methods for introduction of flowable acellular tissue matrix products into a hand
JP7785886B2 (ja) 脂肪組織製品および製造方法
Da et al. and Their Characteristics, Applications in Tissue Repair as Well as Performance Optimization

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211018

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211018

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220920

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230210

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230523

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230823

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231020

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231122

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240227

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240327

R150 Certificate of patent or registration of utility model

Ref document number: 7463273

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150